teamLab Planets in Tokyo Opens a Dining Experience, an Art Space, and a Flower Shop on October 8
27.9.2021 19:00:00 EEST | Business Wire | Press release
teamLab Planets TOKYO in Toyosu, Tokyo welcomes “Vegan Ramen UZU Tokyo” from Kyoto; a new artwork space; and a flower shop where visitors can take home the orchids used in one of the museum’s artworks. “Vegan Ramen UZU Kyoto” opened in Kyoto in March of 2020, becoming hugely popular with hour-long wait times. At “Vegan Ramen UZU Tokyo,” vegan ramen can be enjoyed in the Reversible Rotation - Non-Objective Space or Table of Sky and Fire artwork spaces.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210927005038/en/
Soy Sauce Vegan Ramen (Photo: Business Wire)
There will also be a new flower shop, “teamLab Flower Shop & Art,” where visitors can take home orchids used in the artwork Floating Flower Garden: Flowers and I are of the Same Root, the Garden and I are One, in which visitors become one with over 13,000 orchids. All of these facilities open on Friday, October 8 to the public, not just to teamLab Planets museumgoers.
Vegan Ramen UZU Tokyo : https://vegan-uzu.com/pages/uzu-tokyo-en
teamLab Planets Museum Details: planets.teamlab.art
teamLab Planets Highlight Video: https://youtu.be/xofyyJYYWMY
[Vegan Ramen UZU]
At "Vegan Ramen UZU Kyoto,” which opened in March of 2020 in Gosho-Minami, Kyoto, teamLab was responsible for designing the space and other aspects of the restaurant, where guests can enjoy vegan food while surrounded by art.
“Vegan Ramen UZU Tokyo,” which will open at teamLab Planets, will have vegan ramen available for takeout, as well as to enjoy at the newly-opened Reversible Rotation - Non-Objective Space and Table of Sky and Fire artwork spaces. Flower Vegan Ramen, Green Tea Vegan Ramen, and Vegan Ice Cream will also be available only at “Vegan Ramen UZU Tokyo.”
Official Website: https://vegan-uzu.com/
Media Coverage of “Vegan Ramen UZU Kyoto”
-
Time Out
“teamLab has designed a vegan ramen restaurant in Kyoto”
https://www.timeout.com/tokyo/news/teamlab-has-designed-a-vegan-ramen-restaurant-in-kyoto-012021
Vegan Ramen Menu
- Soy Sauce Vegan Ramen
- Miso Vegan Ramen (Spicy)
[Vegan Ramen UZU Tokyo Only Menu]
- Green Tea Vegan Ramen
- Flower Vegan Ramen (Cold)
[New Public Artworks]
Reversible Rotation - Non-Objective Space
teamLab, 2021, Digital Installation, Sound: Hideaki Takahashi
Artwork: https://planets.teamlab.art/tokyo/ew/reversiblerotation_nonobjective/
The artwork space is freed from the physical boundaries of the surfaces of tables or chairs.
The Spatial Calligraphy rotates in the artwork space, every aspect rotating in the same direction. But because of the special characteristics of Ultrasubjective Space, it can appear to be rotating clockwise or counterclockwise.
Spatial calligraphy is calligraphy drawn in space, a form of calligraphy that teamLab has been exploring since it was founded. The artwork reconstructs calligraphy in three dimensional space to express the depth, speed and power of the brush stroke, and that calligraphy is then flattened using the logical structure teamLab calls ultrasubjective space. The calligraphy shifts between two and three dimensions.
Table of Sky and Fire
teamLab Architects, 2021
Artwork: https://planets.teamlab.art/tokyo/ew/tableskyfire_planets/
This table reflects the sky and the Universe of Fire Particles Falling from the Sky. The table is connected to the artwork and to the sky.
Human beings need to be connected to the world to live. teamLab hopes that people will eat something on this table while thinking that to live and to eat is to stay connected to the world.
[teamLab Flower Shop & Art]
This is a flower shop where visitors can take home orchids used in the artwork Floating Flower Garden: Flowers and I are of the Same Root, the Garden and I are One (photo above), in which visitors become one with over 13,000 orchids.
Orchids live on even after the flowers have fallen, blooming again and again, sometimes for decades. In order for people to take home a part of the work, we sell tote bags containing a variety of orchids. Those who wish to purchase orchids separately may do so from a more limited selection of orchid species.
[teamLab Planets]
teamLab Planets is a museum where you walk through water, and a garden where you become one with the flowers. There are four massive exhibition spaces and two gardens.
By immersing the entire body with other people in these massive body immersive artworks, the boundary between the body and the artwork dissolves, the boundaries between the self, others, and the world become continuous, and we explore a new relationship without boundaries between ourselves and the world.
Enter barefoot, immerse your body with others in the artwork spaces, and become one with the world.
[Summary]
Vegan Ramen UZU Tokyo
https://vegan-uzu.com/pages/uzu-tokyo-en
Open Hours:
October
Mondays - Fridays 11:00 - 19:00
Saturdays 10:30 - 20:00
Sundays 10:30 - 19:00
Closed: same as closed days for teamLab Planets
teamLab Flower Shop & Art
Open Hours:
October
Mondays - Fridays 11:00 - 19:00
Saturdays 10:00 - 20:00
Sundays 10:00 - 19:00
Closed: same as closed days for teamLab Planets
teamlab Planets TOKYO
https://planets.teamlab.art/tokyo/
#teamLabPlanets
Term: July 7, 2018 - End of 2022
Venue: teamLab Planets TOKYO (6 Chome-1-16 Toyosu, Koto City, Tokyo)
Hours:
September: Mon - Fri 10:00 - 20:00 / Sat, Sun, Holidays 9:00-20:00
October: Mon - Fri 10:00 - 19:00 / Sat 9:00 - 20:00 / Sun 9:00 - 19:00
* Last entry 1 hour before closing
Closed: October 5
Admission:
[Entrance Pass]
Adults (ages 18 and older): JPY 3,200
University / Trade School Students: JPY 2,500
Middle School / High School Students: JPY 2,000
Children (ages 4 - 12): JPY 300
Infants (ages 3 and younger): Free
Seniors (ages 65 and older): JPY 2,400
Visitors with Disabilities: JPY 1,600
teamLab Planets TOKYO Ticket Store: https://teamlabplanets.dmm.com/en
* Admission and exhibition hours are subject to change. Please check the official website for the latest information.
* A separate admission fee is required for the newly-opened artwork space Reversible Rotation - Non-Objective Space. This space is also open to visitors other than teamLab Planets museumgoers.
Official Social Media Pages:
Instagram: https://www.instagram.com/teamlab.planets/
Facebook: https://www.facebook.com/TL.Planets/
Twitter: https://twitter.com/teamLabPlanets
Measures Against the Spread of COVID-19:
Infection prevention measures such as entry restrictions are being implemented. Please check the website for details.
https://teamlabplanets.dmm.com/en/covid-19
[Press Kit]
https://goo.gl/tQXMLm
[Media Inquiries]
https://goo.gl/forms/fqn8DmGV8WWIntP53
[PLANETS Co., Ltd.]
The managing entity for facilities operations at teamLab Planets TOKYO
Address: Tokyo Nihonbashi Tower 26F, 2-7-1 Nihonbashi, Chuo-ku, Tokyo
[About teamLab]
teamLab (f. 2001) is an international art collective, an interdisciplinary group of various specialists such as artists, programmers, engineers, CG animators, mathematicians and architects whose collaborative practice seeks to navigate the confluence of art, science, technology, and the natural world.
teamLab aims to explore the relationship between the self and the world and new perceptions through art. In order to understand the world around them, people separate it into independent entities with perceived boundaries between them. teamLab seeks to transcend these boundaries in our perception of the world, of the relationship between the self and the world, and of the continuity of time. Everything exists in a long, fragile yet miraculous, borderless continuity.
teamLab has been the subject of numerous exhibitions at venues worldwide, including New York, London, Paris, Singapore, Silicon Valley, Beijing, Taipei, and Melbourne among others. The permanent museums teamLab Borderless opened in Odaiba,Tokyo in June 2018, and teamLab Borderless Shanghai in Huangpu District, Shanghai in November 2019. teamLab Planets, a museum where you walk through water and a garden where you become one with the flowers in Toyosu, Tokyo is on view until the end of 2022. The large-scale permanent exhibition teamLab SuperNature soft opened in Macao in June, 2020. teamLab’s annual life-work exhibition, VOLVO teamLab: A Forest Where Gods Live, is on view in Mifuneyama Rakuen, Takeo Hot Springs, Kyushu until November 7, 2021.
teamLab’s works are in the permanent collection of the Museum of Contemporary Art, Los Angeles; Art Gallery of New South Wales, Sydney; Art Gallery of South Australia, Adelaide; Asian Art Museum, San Francisco; Asia Society Museum, New York; Borusan Contemporary Art Collection, Istanbul; National Gallery of Victoria, Melbourne; and Amos Rex, Helsinki.
teamLab is represented by Pace Gallery, Martin Browne Contemporary, and Ikkan Art.
teamLab: https://www.teamlab.art/
Instagram: https://instagram.com/teamlab/
Facebook: https://www.facebook.com/teamLab.inc
Twitter: https://twitter.com/teamLab_net
YouTube: https://www.youtube.com/c/teamLabART
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210927005038/en/
Contact information
Shusuke Sasahara
Public Relations, PLANETS Co., Ltd.
Email: pr-info@planets.art
Additional coverage: https://goo.gl/forms/fqn8DmGV8WWIntP53
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
U.S. FDA Grants Priority Review to BeOne Medicines’ BRUKINSA Combination in First-Line Mantle Cell Lymphoma4.11.2026 16:13:00 EET | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review to the supplemental New Drug Application (sNDA) for BRUKINSA® (zanubrutinib) in combination with rituximab for the treatment of adult patients with previously untreated mantle cell lymphoma (MCL). The application is supported by data from the pivotal Phase 3 MANGROVE study, in which this chemotherapy-free regimen significantly reduced the risk of disease progression or death compared with standard chemoimmunotherapy. Full results from the MANGROVE study will be presented during the Plenary Scientific Session at the 68th American Society of Hematology (ASH) Annual Meeting on December 13, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261103605806/en/ BeOne Medicines' flagship U.S. manufacturing and clinical R&D facility at the P
Incyte to Present New Data Highlighting Progress Across its Hematology Portfolio at ASH 20264.11.2026 16:00:00 EET | Press release
Incyte (Nasdaq:INCY) today announced that new data highlighting progress across its hematology portfolio will be presented across more than 30 abstracts at the 2026 American Society of Hematology (ASH) Annual Meeting, to beheld December 12 – 15, 2026, in New Orleans. “Our ASH presentations demonstrate meaningful progress across our Hematology portfolio to advance novel treatment approaches for people with serious hematologic conditions,” said Pablo J. Cagnoni, M.D., President, Incyte and Global Head of Research and Development. "We are particularly encouraged by the continued clinical progress of INCA033989 in myelofibrosis (MF) and essential thrombocythemia (ET) and the data for latarcibart in von Willebrand disease (VWD) - data that support our goal of advancing differentiated medicines with the potential to meaningfully improve outcomes for patients." Details on key data presentations at ASH include: Oral Presentations INCA033989 (mutCALR) In JAK-Inhibitor Naive Patients with Myelof
Rimini Street Awarded CANUT Third-Party Maintenance Framework Agreement4.11.2026 16:00:00 EET | Press release
Rimini Street, Inc. (Nasdaq: RMNI), the Software Support and Agentic AI ERP Company™ and the leading third-party support provider for Oracle, SAP and VMware software, today announced that it had been selected as the awardee of the third-party support service lots (TMA) by CANUT, the French public purchasing center specializing in digital technology and telecommunications. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261104431817/en/ Rimini Street Awarded CANUT Third-Party Maintenance Framework Agreement Eligible public organizations subject to the French Public Procurement Code can now benefit from Rimini Street services for their Oracle, SAP, VMware and IBM environments, without having to go through a lengthy individual tender process. Through Rimini Support™, organizations gain access to a support alternative enabling them to significantly reduce their historical support costs, improve service quality and support respons
Zenitar Announces Initiation of International Randomized Study of Flonoltinib Maleate in Patients with Myelofibrosis and Related American Society of Hematology 2026 Meeting Presentations4.11.2026 16:00:00 EET | Press release
Chengdu Zenitar Biomedical Technology Co., Ltd. (Zenitar) is developing flonoltinib maleate (FM), a first-in-class oral JAK2/FLT3/CDK6 inhibitor for myeloproliferative neoplasms (MPNs), including myelofibrosis (MF) and polycythemia vera (PV). Zenitar launched randomized Phase 2 FM-MF-02 (NCT07750574) in the US, Canada and Brazil to select Phase 3 dose for JAKi-naïve and refractory MF. Randomized FMF-02 (NCT06457425) met its week-24 endpoints: superior SVR35 and TSS50 with FM 50/100mg versus ruxolitinib; previous data presented orally at ASH24 (#486) and ASH25 (#908). ASH 2026 presence covers FMF-02 long-term follow-up (oral presentation, #411, December 12, 4:30pm) and refractory PV Phase 2 data (poster, #3765, December 13, 6pm), both in Session 634. “Over the 15 years since the initial FDA approval of Ruxolitinib, JAKi have markedly improved the prognosis of many patients with MF. The long-term data show significant room for improvement for this key therapeutic class in terms of both e
Trained Therapeutix Discovery Appoints Andrew Glass as Chief Executive Officer4.11.2026 15:41:00 EET | Press release
Trained Therapeutix Discovery ("TTxD"), a pioneering immunotherapy company founded by the Jean Boulle Group and the Heritage Group, which is developing nanomedicines to regulate innate immunity, announces the appointment of Andrew Glass as Chief Executive Officer with immediate effect. Mr. Glass has more than 20 years of leadership experience in the life sciences industry as Chief Executive Officer of Vivasure Medical and previously from over 15 years in senior leadership roles at Abbott. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261104178009/en/ Andrew Glass, CEO, TTxD Following the previously announced changes to the Company’s Board earlier this year, Mr. Glass joins the Company as it transitions from preclinical stage to being a clinical-stage organisation. His expertise in developmental strategy, financing and organisational growth is focussed on expediting the delivery of the aims associated with TTxD’s proprietary
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
